Failure of intravenous or intracardiac delivery of mesenchymal stromal cells to improve outcomes after focal traumatic brain injury in the female rat

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Turtzo, L Christine ^a,b   Budde, Matthew D ^b,e   Dean, Dana D ^b,f   Gold, Eric M ^a,b,g   Lewis, Bobbi K ^b   Janes, Lindsay ^a,b   Lescher, Jacob ^a,b   Coppola, Tiziana ^b   Yarnell, Angela ^c,h   Grunberg, Neil E ^c   Frank, Joseph A ^b,d  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Uniformed Services University of the Health Sciences   (United States)

^d NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f Scott and White Healthcare   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CELL LABELING; CELL SURVIVAL; CELL TRACKING; CELL TRANSPLANTATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CONVALESCENCE; EX VIVO STUDY; FEMALE; FOCAL TRAUMATIC BRAIN INJURY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MESENCHYMAL STROMA CELL TRANSPLANTATION; NANOPHARMACEUTICS; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; RAT; TRAUMATIC BRAIN INJURY; TREATMENT FAILURE; TREATMENT OUTCOME; ANIMAL; BIOLOGICAL THERAPY; BRAIN; BRAIN INJURIES; CELL CULTURE; CYTOLOGY; DISEASE MODEL; HEART CATHETER; HUMAN; IMAGE PROCESSING; INTRAVENOUS DRUG ADMINISTRATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PATHOLOGY; PROCEDURES; WISTAR RAT;

RATTUS; RODENTIA;

ADMINISTRATION, INTRAVENOUS; ANIMALS; BRAIN; BRAIN INJURIES; CARDIAC CATHETERS; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RATS, WISTAR; TREATMENT FAILURE;

EID: 84929105130     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126551     Document Type: Article

References (70)

1. Centers for Disease Control website. Rates of TBI-related Emergency Department Visits, Hospitalizations, and Death - United States, 2001-2010. Available: http://www.cdc.gov/traumaticbraininjury/data/rates.html. Accessed 29 July 2014.
2. Centers for Disease Control website. Rates of TBI-related Deaths by Sex - United States, 2001-2010. Available: http://www.cdc.gov/traumaticbraininjury/data/rates-deaths-bysex.html. Accessed 29 July 2014.
3. Diaz-Arrastia R, Kochanek PM, Bergold P, Kenney K, Marx CE, Grimes CJ, et al. Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup. J Neurotrauma. 2014; 31(2):135-58. Epub 2013/08/24. doi: 10.1089/neu.2013.3019 PMID: 23968241; PubMed Central PMCID: PMC3900003.
4. Yang B, El Khoury R, Savitz SI. MSCs for the Treatment of Stroke, Spinal Cord Injury, and Traumatic Brain Injury: From Bench Work to Clinical Trials. In: Hemati P, Keating A, editors. Mesenchymal Stromal Cells: Biology and Clinical Applications: Humana Press; 2013. p. 617-38.
5. Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta JA. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med. 2010; 5(6):933-46. Epub 2010/11/19. doi: 10.2217/rme.10.72 PMID: 21082892; PubMed Central PMCID: PMC3017479.
6. Lu D, Li Y, Wang L, Chen J, Mahmood A, Chopp M. Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury. J Neurotrauma. 2001; 18(8):813-9. Epub 2001/08/31. doi: 10.1089/089771501316919175 PMID: 11526987.
7. Lu D, Mahmood A, Wang L, Li Y, Lu M, Chopp M. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport. 2001; 12(3):559-63. Epub 2001/03/10. PMID: 11234763.
8. Mahmood A, Lu D, Wang L, Li Y, Lu M, Chopp M. Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells. Neurosurgery. 2001; 49(5):1196-203; discussion 203-4. Epub 2002/02/16. PMID: 11846913.
9. Turtzo LC, Budde MD, Gold EM, Lewis BK, Janes L, Yarnell A, et al. The evolution of traumatic brain injury in a rat focal contusion model. NMR Biomed. 2012; 26:468-79. Epub 2012/12/12. doi: 10.1002/nbm.2886 PMID: 23225324; PubMed Central PMCID: PMC3596464.
10. Bianco P, Kuznetsov SA, Riminucci M, Gehron Robey P. Postnatal skeletal stem cells. Methods in enzymology. 2006; 419:117-48. Epub 2006/12/05. doi: 10.1016/S0076-6879(06)19006-0 PMID: 17141054.
11. Pawelczyk E, Jordan EK, Balakumaran A, Chaudhry A, Gormley N, Smith M, et al. In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages. PLoS One. 2009; 4(8):e6712. Epub 2009/08/22. doi: 10.1371/journal.pone.0006712 PMID: 19696933; PubMed Central PMCID: PMC2726631.
12. Sabatino M, Ren J, David-Ocampo V, England L, McGann M, Tran M, et al. The establishment of a bank of stored clinical bone marrow stromal cell products. J Transl Med. 2012; 10:23. Epub 2012/02/09. doi: 10.1186/1479-5876-10-23 PMID: 22309358; PubMed Central PMCID: PMC3309931.
13. Stroncek DF, Sabatino M, Ren J, England L, Kuznetsov SA, Klein HG, et al. Establishing a bone marrow stromal cell transplant program at the National Institutes of Health Clinical Center. Tissue engineering Part B, Reviews. 2014; 20(3):200-5. Epub 2013/12/26. doi: 10.1089/ten.TEB.2013.0529 PMID: 24368014; PubMed Central PMCID: PMC4030651.
14. Ziadloo A, Burks SR, Gold EM, Lewis BK, Chaudhry A, Merino MJ, et al. Enhanced homing permeability and retention of bone marrow stromal cells (BMSC) by non-invasive pulsed focused ultrasound. Stem Cells 2012. doi: 10.1002/stem.1099
15. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood. 2004; 104(4):1217-23. Epub 2004/04/22. doi: 10.1182/blood-2004-02-0655 PMID: 15100158.
16. Janic B, Rad AM, Jordan EK, Iskander AS, Ali MM, Varma NR, et al. Optimization and validation of FePro cell labeling method. PLoS One. 2009; 4(6):e5873. Epub 2009/06/12. doi: 10.1371/journal.pone. 0005873 PMID: 19517015; PubMed Central PMCID: PMC2690694.
17. Schrepfer S, Deuse T, Reichenspurner H, Fischbein MP, Robbins RC, Pelletier MP. Stem cell transplantation: the lung barrier. Transplant Proc. 2007; 39(2):573-6. Epub 2007/03/17. doi: 10.1016/j.transproceed.2006.12.019 PMID: 17362785.
18. Turtzo LC, Lescher J, Janes L, Dean DD, Budde MD, Frank JA. Macrophagic and microglial responses after focal traumatic brain injury in the female rat. J Neuroinflammation. 2014; 11:82. Epub 2014/04/26. doi: 10.1186/1742-2094-11-82 PMID: 24761998; PubMed Central PMCID: PMC4022366.
19. Rahman MA, Grunberg NE, Mueller GP. Disulfiram causes sustained behavioral and biochemical effects in rats. Pharmacol Biochem Behav. 1997; 56(3):409-15. Epub 1997/03/01. PMID: 9077576.
20. Cole JT, Yarnell A, Kean WS, Gold E, Lewis B, Ren M, et al. Craniotomy: true sham for traumatic brain injury, or a sham of a sham? J Neurotrauma. 2011; 28(3):359-69. Epub 2010/12/31. doi: 10.1089/neu.2010.1427 PMID: 21190398; PubMed Central PMCID: PMC3057208.
21. Britt JM, Kane JR, Spaeth CS, Zuzek A, Robinson GL, Gbanaglo MY, et al. Polyethylene glycol rapidly restores axonal integrity and improves the rate of motor behavior recovery after sciatic nerve crush injury. J Neurophysiol. 2010; 104(2):695-703. Epub 2010/05/07. doi: 10.1152/jn.01051.2009 PMID: 20445038.
22. Schallert T. Disentangling multiple types of recovery from brain injury. In: Kriegelstein J, Klumpp S, editors. Pharmacology of Cerebral Ischemia. Stuttgart: Medpharm Scientific Publishers; 2002. p. 201-16.
23. Miller JD, Lankford SM, Adler KB, Brody AR. Mesenchymal stem cells require MARCKS protein for directed chemotaxis in vitro. American journal of respiratory cell and molecular biology. 2010; 43(3):253- 8. Epub 2010/03/13. doi: 10.1165/rcmb.2010-0015RC PMID: 20224071; PubMed Central PMCID: PMC3159077.
24. Mishima Y, Lotz M. Chemotaxis of human articular chondrocytes and mesenchymal stem cells. Journal of orthopaedic research: official publication of the Orthopaedic Research Society. 2008; 26(10):1407- 12. Epub 2008/05/09. doi: 10.1002/jor.20668 PMID: 18464249.
25. Arbab AS, Janic B, Haller J, Pawelczyk E, Liu W, Frank JA. In Vivo Cellular Imaging for Translational Medical Research. Current medical imaging reviews. 2009; 5(1):19-38. doi: 10.2174/157340509787354697 PMID: 19768136; PubMed Central PMCID: PMC2746660.
26. Budde MD, Frank JA. Magnetic tagging of therapeutic cells for MRI. J Nucl Med. 2009; 50(2):171-4. doi: 10.2967/jnumed.108.053546 PMID: 19164242; PubMed Central PMCID: PMC2633027.
27. Naumova AV, Modo M, Moore A, Murry CE, Frank JA. Clinical imaging in regenerative medicine. Nature biotechnology. 2014; 32(8):804-18. doi: 10.1038/nbt.2993 PMID: 25093889; PubMed Central PMCID: PMC4164232.
28. Mahmood A, Lu D, Chopp M. Marrow stromal cell transplantation after traumatic brain injury promotes cellular proliferation within the brain. Neurosurgery. 2004; 55(5):1185-93. Epub 2004/10/29. PMID: 15509325.
29. Mahmood A, Lu D, Chopp M. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma. 2004; 21(1):33-9. Epub 2004/02/28. doi: 10.1089/089771504772695922 PMID: 14987463.
30. Mahmood A, Lu D, Lu M, Chopp M. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery. 2003; 53(3):697-702; discussion-3. Epub 2003/08/29. PMID: 12943585.
31. Mahmood A, Lu D, Qu C, Goussev A, Chopp M. Human marrow stromal cell treatment provides longlasting benefit after traumatic brain injury in rats. Neurosurgery. 2005; 57(5):1026-31; discussion-31. Epub 2005/11/15. PMID: 16284572; PubMed Central PMCID: PMC1570382.
32. Mahmood A, Lu D, Qu C, Goussev A, Chopp M. Long-term recovery after bone marrow stromal cell treatment of traumatic brain injury in rats. J Neurosurg. 2006; 104(2):272-7. Epub 2006/03/03. doi: 10.3171/jns.2006.104.2.272 PMID: 16509501.
33. Harting MT, Jimenez F, Xue H, Fischer UM, Baumgartner J, Dash PK, et al. Intravenous mesenchymal stem cell therapy for traumatic brain injury. J Neurosurg. 2009; 110(6):1189-97. Epub 2009/03/24. doi: 10.3171/2008.9.JNS08158 PMID: 19301973; PubMed Central PMCID: PMC2889620.
34. Burns TC, Ortiz-Gonzalez XR, Gutierrez-Perez M, Keene CD, Sharda R, Demorest ZL, et al. Thymidine analogs are transferred from prelabeled donor to host cells in the central nervous system after transplantation: a word of caution. Stem Cells. 2006; 24(4):1121-7. Epub 2005/12/24. doi: 10.1634/ stemcells.2005-0463 PMID: 16373692.
35. Lu D, Sanberg PR, Mahmood A, Li Y, Wang L, Sanchez-Ramos J, et al. Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant. 2002; 11(3):275-81. Epub 2002/06/22. PMID: 12075993.
36. Mahmood A, Lu D, Wang L, Chopp M. Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury. J Neurotrauma. 2002; 19(12):1609-17. Epub 2003/01/25. doi: 10.1089/089771502762300265 PMID: 12542861.
37. Bonilla C, Zurita M, Otero L, Aguayo C, Vaquero J. Delayed intralesional transplantation of bone marrow stromal cells increases endogenous neurogenesis and promotes functional recovery after severe traumatic brain injury. Brain Inj. 2009; 23(9):760-9. Epub 2009/07/29. doi: 10.1080/02699050903133970 PMID: 19637001.
38. Heile AM, Wallrapp C, Klinge PM, Samii A, Kassem M, Silverberg G, et al. Cerebral transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury. Neurosci Lett. 2009; 463(3):176-81. doi: 10.1016/j.neulet.2009.07.071 PMID: 19638295.
39. Lundberg J, Le Blanc K, Soderman M, Andersson T, Holmin S. Endovascular transplantation of stem cells to the injured rat CNS. Neuroradiology. 2009; 51(10):661-7. doi: 10.1007/s00234-009-0551-6 PMID: 19562330.
40. Cheng JL, Yang YJ, Li HL, Wang J, Wang MH, Zhang Y. In vivo tracing of superparamagnetic iron oxide-labeled bone marrow mesenchymal stem cells transplanted for traumatic brain injury by susceptibility weighted imaging in a rat model. Chin J Traumatol. 2010; 13(3):173-7. Epub 2010/06/03. PMID: 20515596.
41. Bonilla C, Zurita M, Otero L, Aguayo C, Rico MA, Vaquero J. The severity of brain damage determines bone marrow stromal cell therapy efficacy in a traumatic brain injury model. The journal of trauma and acute care surgery. 2012; 72(5):1203-12; discussion 11-2. Epub 2012/06/08. doi: 10.1097/TA.0b013e318248bdcf PMID: 22673246.
42. Bonilla C, Zurita M, Otero L, Aguayo C, Rico MA, Rodriguez A, et al. Failure of delayed intravenous administration of bone marrow stromal cells after traumatic brain injury. J Neurotrauma. 2012; 29(2):394-400. Epub 2011/10/18. doi: 10.1089/neu.2011.2101 PMID: 21999525.
43. Jiang JD, Bu XY, Liu M, Cheng PX. Transplantation of autologous bone marrow-derived mesenchymal stem cells for traumatic brain injury. Neural Regen Res. 2012; 7(1):46-53. doi: 10.3969/J.Issn.1673-5374.2012.01.008 PMID: ISI:000299915000009.
44. Osanai T, Kuroda S, Sugiyama T, Kawabori M, Ito M, Shichinohe H, et al. Therapeutic effects of intraarterial delivery of bone marrow stromal cells in traumatic brain injury of rats-in vivo cell tracking study by near-infrared fluorescence imaging. Neurosurgery. 2012; 70(2):435-44; discussion 44. Epub 2011/08/09. doi: 10.1227/NEU.0b013e318230a795 PMID: 21822154.
45. Bedi SS, Hetz R, Thomas C, Smith P, Olsen AB, Williams S, et al. Intravenous multipotent adult progenitor cell therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury. Stem cells translational medicine. 2013; 2(12):953-60. Epub 2013/11/06. doi: 10.5966/sctm.2013-0100 PMID: 24191266; PubMed Central PMCID: PMC3841090.
46. Bedi SS, Walker PA, Shah SK, Jimenez F, Thomas CP, Smith P, et al. Autologous bone marrow mononuclear cells therapy attenuates activated microglial/macrophage response and improves spatial learning after traumatic brain injury. The journal of trauma and acute care surgery. 2013; 75(3):410-6. Epub 2013/08/10. doi: 10.1097/TA.0b013e31829617c6 PMID: 23928737; PubMed Central PMCID: PMC4086922.
47. Acosta SA, Tajiri N, Shinozuka K, Ishikawa H, Sanberg PR, Sanchez-Ramos J, et al. Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury. PLoS One. 2014; 9(3):e90953. doi: 10.1371/journal.pone.0090953 PMID: 24621603; PubMed Central PMCID: PMC3951247.
48. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009; 18(5):683-92. Epub 2008/12/23. doi: 10.1089/scd.2008.0253 PMID: 19099374.
49. Eggenhofer E, Benseler V, Kroemer A, Popp FC, Geissler EK, Schlitt HJ, et al. Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Frontiers in immunology. 2012; 3:297. Epub 2012/10/12. doi: 10.3389/fimmu.2012.00297 PMID: 23056000; PubMed Central PMCID: PMC3458305.
50. Everaert BR, Bergwerf I, De Vocht N, Ponsaerts P, Van Der Linden A, Timmermans JP, et al. Multimodal in vivo imaging reveals limited allograft survival, intrapulmonary cell trapping and minimal evidence for ischemia-directed BMSC homing. BMC biotechnology. 2012; 12:93. Epub 2012/12/05. doi: 10. 1186/1472-6750-12-93 PMID: 23206380; PubMed Central PMCID: PMC3534291.
51. Goldmacher GV, Nasser R, Lee DY, Yigit S, Rosenwasser R, Iacovitti L. Tracking transplanted bone marrow stem cells and their effects in the rat MCAO stroke model. PLoS One. 2013; 8(3):e60049. Epub 2013/04/05. doi: 10.1371/journal.pone.0060049 PMID: 23555879; PubMed Central PMCID: PMC3612030.
52. Kerkela E, Hakkarainen T, Makela T, Raki M, Kambur O, Kilpinen L, et al. Transient proteolytic modification of mesenchymal stromal cells increases lung clearance rate and targeting to injured tissue. Stem cells translational medicine. 2013; 2(7):510-20. Epub 2013/06/05. doi: 10.5966/sctm.2012-0187 PMID: 23734061; PubMed Central PMCID: PMC3697819.
53. Harting M, Jimenez F, Pati S, Baumgartner J, Cox C Jr. Immunophenotype characterization of rat mesenchymal stromal cells. Cytotherapy. 2008; 10(3):243-53. doi: 10.1080/14653240801950000 PMID: 18418770.
54. Walker PA, Jimenez F, Gerber MH, Aroom KR, Shah SK, Harting MT, et al. Effect of needle diameter and flow rate on rat and human mesenchymal stromal cell characterization and viability. Tissue Eng Part C Methods. 2010; 16(5):989-97. Epub 2009/12/17. doi: 10.1089/ten.TEC.2009.0423 PMID: 20001789; PubMed Central PMCID: PMC2943405.
55. Cooper DJ, Rosenfeld JV, Murray L, Arabi YM, Davies AR, D'Urso P, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011; 364(16):1493-502. Epub 2011/03/26. doi: 10. 1056/NEJMoa1102077 PMID: 21434843.
56. Gold EM, Su D, Lopez-Velazquez L, Haus DL, Perez H, Lacuesta GA, et al. Functional assessment of long-term deficits in rodent models of traumatic brain injury. Regen Med. 2013; 8(4):483-516. Epub 2013/07/06. doi: 10.2217/rme.13.41 PMID: 23826701.
57. Cullen KM, Kocsi Z, Stone J. Pericapillary haem-rich deposits: evidence for microhaemorrhages in aging human cerebral cortex. J Cereb Blood Flow Metab. 2005; 25(12):1656- 67. Epub 2005/05/27. 9600155 [pii] doi: 10.1038/sj.jcbfm.9600155 PMID: 15917745.
58. Schroder R, Reinartz B. The lipopigments in human brain tissue necroses. II. Hemoceroid. Acta Neuropathol. 1980; 52(2):147-51. Epub 1980/01/01. PMID: 7435165.
59. Baschong W, Suetterlin R, Laeng RH. Control of autofluorescence of archival formaldehyde-fixed, paraffin-embedded tissue in confocal laser scanning microscopy (CLSM). J Histochem Cytochem. 2001; 49(12):1565-72. Epub 2001/11/29. PMID: 11724904.
60. Clayton JA, Collins FS. Policy: NIH to balance sex in cell and animal studies. Nature. 2014; 509 (7500):282-3. PMID: 24834516.
61. Gahrton G, Iacobelli S, Apperley J, Bandini G, Bjorkstrand B, Blade J, et al. The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone marrow transplantation. 2005; 35(6):609-17. Epub 2005/02/08. doi: 10.1038/sj.bmt.1704861 PMID: 15696179.
62. Fessart D, Dromer C, Thumerel M, Jougon J, Delom F. Influence of gender donor-recipient combinations on survival after human lung transplantation. Transplant Proc. 2011; 43(10):3899-902. Epub 2011/12/17. doi: 10.1016/j.transproceed.2011.08.101 PMID: 22172868.
63. Zeier M, Dohler B, Opelz G, Ritz E. The effect of donor gender on graft survival. Journal of the American Society of Nephrology: JASN. 2002; 13(10):2570-6. Epub 2002/09/20. PMID: 12239247.
64. Zhou JY, Cheng J, Huang HF, Shen Y, Jiang Y, Chen JH. The effect of donor-recipient gender mismatch on short- and long-term graft survival in kidney transplantation: a systematic review and metaanalysis. Clinical transplantation. 2013; 27(5):764-71. Epub 2013/07/25. doi: 10.1111/ctr.12191 PMID: 23879398.
65. Walker PA, Shah SK, Jimenez F, Gerber MH, Xue H, Cutrone R, et al. Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes. Exp Neurol. 2010; 225(2):341-52. Epub 2010/07/20. doi: 10.1016/j.expneurol.2010. 07.005 PMID: 20637752.
66. Walker PA, Bedi SS, Shah SK, Jimenez F, Xue H, Hamilton JA, et al. Intravenous multipotent adult progenitor cell therapy after traumatic brain injury: modulation of the resident microglia population. J Neuroinflammation. 2012; 9:228. Epub 2012/10/02. doi: 10.1186/1742-2094-9-228 PMID: 23020860; PubMed Central PMCID: PMC3546881.
67. Brenneman M, Sharma S, Harting M, Strong R, Cox CS Jr., Aronowski J, et al. Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab. 2010; 30(1):140-9. Epub 2009/09/24. doi: 10.1038/jcbfm.2009.198 PMID: 19773802; PubMed Central PMCID: PMC2893568.
68. Cox CS Jr., Baumgartner JE, Harting MT, Worth LL, Walker PA, Shah SK, et al. Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery. 2011; 68 (3):588-600. Epub 2010/12/31. doi: 10.1227/NEU.0b013e318207734c PMID: 21192274.
69. Savitz SI, Misra V, Kasam M, Juneja H, Cox CS Jr., Alderman S, et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol. 2011; 70(1):59- 69. Epub 2011/07/26. doi: 10.1002/ana.22458 PMID: 21786299.
70. Kim S, Chaudhry A, Lee I, Frank JA. Effects of long-term hypoxia and pro-survival cocktail in bone marrow- derived stromal cell survival. Stem Cells Dev. 2014; 23(5):530-40. doi: 10.1089/scd.2013.0297 PMID: 24147599; PubMed Central PMCID: PMC3928716.